Skip to main content
. Author manuscript; available in PMC: 2017 Feb 16.
Published in final edited form as: Int J Obes (Lond). 2016 May 2;40(9):1353–1359. doi: 10.1038/ijo.2016.81

Table 1. Descriptive Statistics.

Primary sample: those with valid MetS severity scores, fasting insulin and adiponectin at the PFS Visit (n = 711). From those 711 participants, the LRC column provides data at the LRC (child) visit for the n = 595 participants < 20 years old and who had valid MetS severity scores at the time. The PHU column provides data on those 417 individuals from the 711 who were followed up during the 2010–2014 period.

Primary Analysis Sample (n = 711)

LRC Visit
1973–1976
PFS Visit
1998–2003
PHU Contact
2010–2014
N 595 711 417
Mean (SD):
 Age (years) 12.9 (3.3) 39.5 (4.7) 50.9 (4.9)
 BMI (kg/m2) 20.0 (4.3) 28.8 (6.8) --
 Waist (cm) -- 97.5 (16.9) --
 Glucose (mg/dL) 85.4 (8.2) 90.6 (27.7) --
 HDL-C (mgl/dL) 54.5 (12.1) 45.3 (14.3) --
 Triglycerides (mg/dL) 74.7 (38.3) 136.7 (115.5) --
 Systolic blood pressure (mm Hg) 102.8 (12.7) 121.0 (15.2) --
 Diastolic blood pressure (mm Hg) 63.1 (11.3) 79.8 (11.1) --
 Metabolic syndrome severity score (z-score) −0.5 (0.8) 0.1 (1.1) --
 Fasting insulin -- 10.9 (9.0) --
 Adiponectin 10.4 (6.8) --
Frequency (Percent):
 Male 259 (43.5%) 316 (44.4%) 174 (41.7%)
 White 418 (70.3%) 502 (70.6%) 321 (77.0%)
 Overweight* 71 (11.9%) 231 (32.5%) --
 Obese* 57 (9.6%) 247 (34.8%) --
 Metabolic syndrome 22 (3.7%) 231 (32.5%) --
 High Insulin (≥ 16) -- 132 (18.6%) --

 T2DM** -- 37 (5.4%) 60 (14.4%)

 Myocardial Infarction** -- 6 (0.9%) 15 (3.7%)
 Stroke** -- 3 (0.4%) 11 (2.8%)
 Angioplasty, Stent, Bypass, or other Heart Surgery** -- 1 (0.1%) 14 (3.5%)

 Cardiovascular Disease** 10 (1.4%) 29 (7.1%)

 Deceased** -- 0 7 (1.7%)
*

Overweight = BMI ≥ 85th percentile for LRC, ≥ 25 for PFS; Obese = BMI ≥ 95th percentile for LRC, ≥ 30 for PFS

**

Cumulative frequencies by the designated visit